← Latest papers
💻 computer science

A Non-Destructive Methodological Framework for Modernizing Legacy Clinical Reporting Systems for AI-Driven Pharmacoinformatics: A SAS Case Study

This paper presents a non-destructive methodological framework that modernizes legacy SAS clinical reporting systems for AI-driven pharmacoinformatics by wrapping existing code with a metadata layer to generate machine-readable outputs, achieving high validation parity and significant code reduction without altering the original source.

Original authors: Jaime Yan

Published 2026-05-15
📖 5 min read🧠 Deep dive

Original authors: Jaime Yan

Original paper licensed under CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

Imagine a pharmaceutical company has a massive, ancient library of instruction manuals. These manuals tell a computer exactly how to calculate drug safety data and create the official reports needed to get new medicines approved by the government.

The Problem: The "Locked Box" Library
For decades, these manuals (written in a language called SAS) have been working perfectly. They are "validated," meaning the government trusts them completely. However, they have a major flaw: they only produce the final report as a pretty, printed document (like a PDF or a Word file).

If you want to ask a modern AI (like a smart robot) to read these reports, find patterns, or help write new ones, the AI is stuck. It can't "read" the pretty document; it can only see the ink on the page. To get the data out, humans have to manually re-type everything or try to guess what the numbers mean. This is slow, boring, and prone to human error.

The company faces a terrible choice:

  1. Tear it all down: Throw away the old, trusted manuals and write brand new ones from scratch. This is risky because if you make a tiny mistake in the new version, the government might reject the drug application.
  2. Leave it alone: Keep the old system, but then you can't use AI, and your drug development stays slow.

The Solution: The "Glass Case" Framework
This paper proposes a clever third option: Don't touch the old manuals at all. Instead, build a smart "glass case" around them.

Here is how the framework works, using simple analogies:

1. The Translator (The Bridge Map)

Imagine the old manuals are written in a secret code. The framework builds a "translator" (called a Bridge Map) that sits right in front of the old system. When the old system runs, the translator doesn't change the code; it just watches what comes out. It says, "Okay, the old system just calculated that 50 patients had a headache. I will write that down in a clear, digital list that a computer can read."

2. The Universal Format (The Intermediate Representation)

The old system usually spits out a messy, formatted report. The framework catches that output and instantly converts it into a clean, structured digital format called an Intermediate Representation (IR).

Think of this like taking a handwritten recipe (the old report) and turning it into a structured database entry.

  • Old way: "53 people (61.6%) were female." (Hard for a robot to parse).
  • New way: Count: 53, Percentage: 61.6, Type: Female. (Easy for a robot to understand).

This happens without changing the original recipe. The old system does the cooking; the framework just organizes the ingredients into a neat box.

3. The Smart Assistant (AI Readiness)

Now that the data is in this clean, digital box, the AI can finally do its job. The paper tested this by asking an AI to:

  • Summarize: "Tell me the main findings about patient ages." The AI could instantly read the digital box and write a summary.
  • Spot Errors: "Is anything weird here?" The AI noticed that as the drug dose went up, side effects went up, which makes sense, but then it spotted a weird dip in diarrhea rates that humans might have missed.
  • Plan Ahead: "Here is a rule for a new study; write the setup file." The AI could read the rule and generate the correct digital configuration file.

4. The "Do-Over" Option (Consolidation)

The paper also mentions a bonus feature. Once the company is comfortable with the "glass case," they can optionally start replacing the old, messy manuals with new, cleaner ones, one by one.

  • The Result: They managed to shrink their code library by 92% (from 558 complex files down to 158 simple ones) by removing duplicates and cleaning up the logic.
  • The Catch: They didn't have to do this to get the AI working. The AI worked from Day 1 just by wrapping the old system.

The Proof: Did it Work?

The researchers tested this on a real, massive industrial library (373,000 lines of code).

  • Real World Test: They ran 14 different types of drug reports. In 11 of them, the new system matched the old system's results perfectly (or within a tiny, acceptable margin of error). The 3 that didn't match perfectly were just due to the layout looking different, not the math being wrong.
  • Public Test: They tested on a public, standard dataset. The new system got 100% perfect on all 5 reports, matching every single number.

The Bottom Line

This framework is like putting a modern, high-tech dashboard on top of an old, classic car. You don't have to rebuild the engine (which is expensive and risky). You just add a layer that translates the engine's power into a format modern tools can use.

This allows pharmaceutical companies to start using AI immediately to speed up drug discovery, without having to throw away the trusted, government-approved systems they have relied on for decades. It's a "non-destructive" upgrade: the old system stays safe and sound, while the new layer unlocks its potential.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →